查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762091

癌症生物標記市場分析及預測（至 2034 年）：類型、產品、服務、技術、應用、最終用戶、安裝類型、功能、階段

Cancer Biomarkers Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Installation Type, Functionality, Stage
出版日期: | 出版商: Global Insight Services | 英文 356 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計癌症生物標記市場規模將從 2024 年的 244 億美元擴大到 2034 年的 603 億美元，複合年成長率約為 9.5%。癌症生物標記市場包括指示癌症存在或進展的生物分子，有助於診斷、預後和治療方法選擇。這些生物標記存在於血液、組織和其他體液中，可透過標靶治療實現個人化醫療。隨著基因組學、蛋白質組學和生物資訊學的進步以及癌症發病率的上升，市場正在不斷擴大。對早期發現和精準醫療的重視正在推動創新，重點是開發非侵入性測試以及將生物標記發現與數位健康技術相結合。

行業概覽

癌症生物標記市場受到全球關稅和地緣政治緊張局勢的複雜影響，尤其是在東亞地區。日本和韓國正在尋求透過加強國內研發來克服貿易壁壘並減少對外國生物技術的依賴。在出口管制和注重自主創新的推動下，中國正加速其向醫學研究自給自足的戰略重心轉變。台灣儘管在生技製造業處於領先地位，但在美國緊張局勢下面臨地緣政治脆弱性。受癌症發病率上升和精準醫療進步的推動，全球癌症生物標記市場強勁成長。在彈性供應鏈和策略聯盟的推動下，預計到 2035 年市場將大幅成長。中東的衝突正在擾亂全球供應鏈，可能影響能源價格和營運成本，進而影響市場動態。

市場區隔
類型 基因生物標記、蛋白質生物標記、代謝組生物標記、表觀遺傳生物標記物
產品 檢測試劑套件、試劑、設備、軟體
服務 樣品製備、生物標記檢驗、生物標記測試、數據分析
科技 次世代定序、聚合酵素鏈鎖反應、免疫測量、質譜、層析法
目的 診斷、藥物研發、預後預測、風險評估
最終用戶 醫院、研究實驗室、製藥和生物技術公司、學術機構
安裝類型 本地部署，雲端基礎
功能 發現、監控和分析
步 早期發現、預後、治療反應及復發

市場概況：

癌症生物標記市場正經歷強勁成長，主要得益於個人化醫療的進步和癌症發生率的上升。蛋白質生物標記細分市場因其在癌症診斷、預後預測和治療監測中的廣泛應用而引領市場。該細分市場在檢測特定癌症類型和指導標靶治療的技術優勢增強了其主導地位。基因生物標記是一個新興的細分市場，由於次世代定序儀的進步和對精準腫瘤學的日益重視而獲得了關注。這些生物標記有可能透過實現早期檢測和個人化治療策略來徹底改變癌症治療。液態切片細分市場包括循環腫瘤 DNA 和基於外泌體的生物標記，由於其非侵入性特性和提供對腫瘤動態的即時洞察的能力，預計將對市場產生重大影響。隨著這些新興細分市場的不斷發展，它們有望提高診斷的準確性和治療效果，從而進一步推動癌症生物標記市場的成長。

競爭概況：

癌症生物標記市場主要受診斷應用驅動，其次是預後預測。這一排名很大程度上是由於人們越來越重視早期癌症檢測和個人化醫療，這導致了對高階診斷能力的需求。按地區分類，北美在強大的研究基礎設施和高額醫療支出的支持下佔據市場主導地位，而亞太地區則因醫療保健投資的增加和癌症發病率的上升而經歷加速成長。同時，由於醫療保健投資的增加和癌症發生率的上升，亞太地區正經歷加速成長。主要產業參與者正在透過策略聯盟和生物標記發現與檢驗方面的創新不斷增強其產品組合。法規結構，尤其是美國和歐洲的監管框架，對於塑造市場動態至關重要，因為它們為生物標記檢驗和臨床使用制定了嚴格的指導方針。隨著基因組學和蛋白​​質組學的進步為新型生物標記的識別和利用鋪平了道路，癌症生物標記市場的未來充滿希望。儘管監管障礙和高開發成本等挑戰依然存在，但人工智慧在生物標記分析中的整合以及向液態切片的轉變提供了巨大的成長機會。

主要趨勢和促進因素：

在精準醫療和個人化醫療的推動下，癌症生物標記市場正經歷強勁成長。主要趨勢包括將人工智慧和機器學習融入生物標記發現，以提高診斷準確性和治療效果。全球癌症發生率的上升需要早期發現和標靶治療，這推動了對創新生物標記解決方案的需求。促進因素包括政府支持癌症研究和生物標記開發的措施和資金支持。液態切片技術的興起提供了非侵入性選擇，提高了患者的依從性和監測能力。此外，製藥公司和研究機構之間的合作正在加速生物標記的研究和商業化。對伴隨診斷的日益重視進一步推動了市場擴張。隨著醫療基礎設施的發展和先進診斷工具的普及，新興市場充滿了機會。專注於開發經濟高效且易於獲取的生物標記解決方案的公司可能會佔據相當大的市場佔有率。基因組學和蛋白​​質組學技術的不斷發展使得更精確、更全面的癌症管理策略成為可能，這指明了進一步的成長途徑。隨著不斷的技術創新和戰略合作夥伴關係，癌症生物標記市場有望持續發展。

限制與挑戰：

癌症生物標記市場面臨許多關鍵限制因素和挑戰。其中一項主要挑戰是生物標記檢驗和開發的高成本，這阻礙了其廣泛應用和商業化。癌症的複雜性和異質性進一步加劇了生物標記的發現，導致研究時間延長和費用增加。新型生物標記的嚴格核准流程延遲了市場准入並增加了成本。此外，各實驗室缺乏標準化的方案和指南，導致檢測結果有差異，從而削弱了可靠性和可信度。用於研究和檢驗的高品質生物樣本的有限性限制了技術創新的步伐。此外，不完善的報銷框架持續減緩了生物標記檢測在臨床上的應用，阻礙了醫療保健提供者使用這些先進的診斷方法。這些挑戰阻礙了癌症生物標記市場的成長和可近性。

目錄

第1章 癌症生物標記市場概述

  • 研究目標
  • 癌症生物標記市場定義和範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章重要考察

第4章癌症生物標記市場展望

  • 癌症生物標記市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章：癌症生物標記市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章 癌症生物標記的市場規模

  • 癌症生物標記市場規模（以價值計算）
  • 癌症生物標記市場規模

第7章 癌症生物標記市場規模（按類型）

  • 市場概覽
  • 基因生物標記
  • 蛋白質體生物標記
  • 代謝組學生物標記
  • 表觀遺傳生物標記
  • 其他

第 8 章 癌症生物標記市場（按產品）

  • 市場概覽
  • 檢測試劑套件
  • 試劑
  • 裝置
  • 軟體
  • 其他

第9章 癌症生物標記市場（按服務）

  • 市場概覽
  • 樣品製備
  • 生物標記檢驗
  • 生物標記檢測
  • 4.數據分析
  • 其他

第 10 章 癌症生物標記市場（按技術）

  • 市場概覽
  • 次世代定序
  • 聚合酵素鏈鎖反應
  • 免疫測量
  • 質譜法
  • 層析法
  • 其他

第 11 章 癌症生物標記市場（按應用）

  • 市場概覽
  • 診斷
  • 藥物研發
  • 預後
  • 風險評估
  • 其他

第 12 章 癌症生物標記市場（按最終用戶）

  • 市場概覽
  • 醫院
  • 研究所
  • 製藥公司
  • 生技公司
  • 學術機構
  • 其他

第13章 癌症生物標記市場（依安裝類型）

  • 市場概覽
  • 本地
  • 雲端基礎
  • 其他

第14章 癌症生物標記市場（按功能）

  • 市場概覽
  • 偵測
  • 監控
  • 分析
  • 其他

第15章 癌症生物標記市場（依階段）

  • 市場概覽
  • 早期檢測
  • 預後
  • 治療反應
  • 復發
  • 其他

第16章 癌症生物標記市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第17章競爭格局

  • 概述
  • 市場佔有率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第18章 公司簡介

  • Biocept
  • Biodesix
  • NantHealth
  • Exact Sciences
  • Myriad Genetics
  • Guardant Health
  • NeoGenomics Laboratories
  • Caris Life Sciences
  • Foundation Medicine
  • Illumina
  • Thermo Fisher Scientific
  • QIAGEN
  • PerkinElmer
  • Roche Diagnostics
  • Agilent Technologies
  • Hologic
  • Sysmex Corporation
  • Bio-Rad Laboratories
  • Quanterix
  • Adaptive Biotechnologies
簡介目錄
Product Code: GIS10251

Cancer Biomarkers Market is anticipated to expand from $24.4 billion in 2024 to $60.3 billion by 2034, growing at a CAGR of approximately 9.5%. Cancer Biomarkers Market encompasses biological molecules that indicate the presence or progression of cancer, aiding in diagnosis, prognosis, and therapy selection. These biomarkers, found in blood, tissue, or other bodily fluids, facilitate personalized medicine by enabling targeted treatments. The market is expanding due to advancements in genomics, proteomics, and bioinformatics, alongside increasing cancer prevalence. Emphasis on early detection and precision medicine drives innovation, with a focus on developing non-invasive tests and integrating biomarker discovery with digital health technologies.

Industry Overview:

The Cancer Biomarkers Market is intricately influenced by global tariffs and geopolitical tensions, particularly in East Asia. Japan and South Korea are navigating trade barriers by bolstering domestic research and development, aiming to reduce dependency on foreign biotechnologies. China's strategic pivot towards self-sufficiency in medical research is accelerating, driven by export restrictions and a focus on indigenous innovation. Taiwan, while leading in biotech manufacturing, faces geopolitical vulnerabilities amidst US-China tensions. The global market for cancer biomarkers is robust, fueled by rising cancer prevalence and advancements in precision medicine. By 2035, the market is poised for significant growth, contingent on resilient supply chains and strategic alliances. Middle East conflicts potentially disrupt global supply chains, influencing energy prices and operational costs, thereby impacting market dynamics.

Market Segmentation
TypeGenomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Epigenetic Biomarkers
ProductAssay Kits, Reagents, Instruments, Software
ServicesSample Preparation, Biomarker Validation, Biomarker Testing, Data Analysis
TechnologyNext-Generation Sequencing, Polymerase Chain Reaction, Immunoassays, Mass Spectrometry, Chromatography
ApplicationDiagnostics, Drug Discovery and Development, Prognostics, Risk Assessment
End UserHospitals, Research Laboratories, Pharmaceutical Companies, Biotechnology Companies, Academic Institutes
Installation TypeOn-Premise, Cloud-Based
FunctionalityDetection, Monitoring, Profiling
StageEarly Detection, Prognosis, Therapeutic Response, Recurrence

Market Overview:

The Cancer Biomarkers Market is experiencing robust growth, primarily driven by advancements in personalized medicine and increasing prevalence of cancer. The protein biomarkers segment leads the market, attributed to their widespread use in cancer diagnosis, prognosis, and therapy monitoring. This segment's dominance is reinforced by its technological superiority in detecting specific cancer types and guiding targeted therapies. Genomic biomarkers are an emerging sub-segment, gaining traction due to advancements in next-generation sequencing and the growing emphasis on precision oncology. These biomarkers offer the potential to revolutionize cancer treatment by enabling early detection and personalized therapeutic strategies. The liquid biopsy sub-segment, encompassing circulating tumor DNA and exosome-based biomarkers, is poised to significantly impact the market due to its non-invasive nature and ability to provide real-time insights into tumor dynamics. As these emerging sub-segments continue to evolve, they promise to enhance diagnostic accuracy and treatment outcomes, driving further growth in the cancer biomarkers landscape.

Geographical Overview:

The cancer biomarkers market is witnessing substantial growth across diverse regions, each with unique dynamics. North America remains at the forefront, propelled by advanced healthcare infrastructure and heightened awareness of personalized medicine. Robust research and development activities further bolster the market's expansion in this region. Europe follows suit, with strong governmental support and investments in cancer research enhancing market growth. The region's emphasis on early diagnosis and prevention strategies significantly contributes to the demand for cancer biomarkers. Asia Pacific is experiencing rapid market expansion due to increasing cancer prevalence and improving healthcare infrastructure. Rising investments in biotechnology and personalized medicine drive the demand for cancer biomarkers. Latin America is an emerging market, with growing awareness of cancer diagnostics and increasing healthcare expenditure. Efforts to improve healthcare access and infrastructure are expected to boost the market further. The Middle East & Africa region is recognizing the potential of cancer biomarkers in improving patient outcomes. Investments in healthcare infrastructure and research initiatives are gradually enhancing market prospects in this region.

Competition Overview:

The cancer biomarkers market is predominantly led by diagnostics applications, with therapeutics and prognostics following closely. This hierarchy is largely influenced by the growing emphasis on early cancer detection and personalized medicine, which necessitate advanced diagnostic capabilities. Geographically, North America remains at the forefront of market leadership, bolstered by robust research infrastructure and high healthcare expenditure, whereas the Asia-Pacific region is witnessing accelerated growth due to increased healthcare investments and rising cancer prevalence. Key industry players are continuously enhancing their portfolios through strategic collaborations and innovations in biomarker discovery and validation. Regulatory frameworks, particularly in the United States and Europe, are pivotal in shaping market dynamics, as they establish stringent guidelines for biomarker validation and clinical use. The future trajectory of the cancer biomarkers market is promising, with advancements in genomics and proteomics paving the way for novel biomarker identification and utilization. While challenges such as regulatory hurdles and high development costs persist, the integration of artificial intelligence in biomarker analysis and the shift towards liquid biopsies present significant growth opportunities.

Recent Developments:

The Cancer Biomarkers Market has experienced notable developments recently. Roche has launched a new cancer biomarker test that promises to enhance early detection capabilities, marking a significant advancement in precision medicine. In M&A news, Thermo Fisher Scientific has acquired a leading biomarker company, aiming to expand its oncology diagnostics portfolio and strengthen its market position. Meanwhile, a strategic partnership was announced between AstraZeneca and Guardant Health to co-develop liquid biopsy tests, enhancing non-invasive cancer detection methods. The European Medicines Agency has updated its guidelines on biomarker validation, emphasizing the importance of robust clinical evidence, which could impact regulatory pathways for new biomarker tests. Lastly, a recent financial report from Bio-Rad Laboratories highlighted a substantial increase in their biomarker division's revenue, attributed to growing demand for personalized cancer therapies. These developments underscore the dynamic nature of the Cancer Biomarkers Market, driven by innovation and strategic collaborations.

Key Companies:

Biocept, Biodesix, Nant Health, Exact Sciences, Myriad Genetics, Guardant Health, Neo Genomics Laboratories, Caris Life Sciences, Foundation Medicine, Illumina, Thermo Fisher Scientific, QIAGEN, Perkin Elmer, Roche Diagnostics, Agilent Technologies, Hologic, Sysmex Corporation, Bio- Rad Laboratories, Quanterix, Adaptive Biotechnologies

Key Trends and Drivers:

The Cancer Biomarkers Market is experiencing robust growth driven by advancements in precision medicine and personalized healthcare. Key trends include the integration of artificial intelligence and machine learning in biomarker discovery, enhancing diagnostic accuracy and treatment efficacy. The increasing prevalence of cancer worldwide necessitates early detection and targeted therapies, propelling demand for innovative biomarker solutions. Drivers include government initiatives and funding supporting cancer research and biomarker development. The rise of liquid biopsy technologies offers non-invasive alternatives, improving patient compliance and monitoring. Additionally, collaborations between pharmaceutical companies and research institutions are accelerating biomarker research and commercialization. The growing emphasis on companion diagnostics is further bolstering market expansion. Opportunities abound in emerging markets where healthcare infrastructure is evolving, and access to advanced diagnostic tools is increasing. Companies that focus on developing cost-effective and accessible biomarker solutions stand to gain significant market share. The continuous evolution of genomic and proteomic technologies presents further avenues for growth, enabling more precise and comprehensive cancer management strategies. With ongoing innovations and strategic partnerships, the Cancer Biomarkers Market is poised for sustained advancement.

Restraints and Challenges:

The Cancer Biomarkers Market encounters several significant restraints and challenges. A primary challenge is the high cost of biomarker validation and development, which hampers widespread adoption and commercialization. The complexity and heterogeneity of cancer further complicate biomarker discovery, leading to prolonged research timelines and increased expenses. Regulatory hurdles present another obstacle, as stringent approval processes for new biomarkers delay market entry and increase costs. Additionally, the lack of standardized protocols and guidelines across laboratories leads to variability in test results, undermining reliability and trust. The limited availability of high-quality biological samples for research and validation constrains the pace of innovation. Furthermore, the integration of biomarker testing into clinical practice remains slow due to inadequate reimbursement frameworks, discouraging healthcare providers from utilizing these advanced diagnostics. These challenges collectively hinder the growth and accessibility of the cancer biomarkers market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Cancer Biomarkers Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Cancer Biomarkers Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Installation Type
  • 2.10 Key Highlights of the Market, by Functionality
  • 2.11 Key Highlights of the Market, by Stage
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Installation Type
  • 3.9 Market Attractiveness Analysis, by Functionality
  • 3.10 Market Attractiveness Analysis, by Stage
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Cancer Biomarkers Market Outlook

  • 4.1 Cancer Biomarkers Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Cancer Biomarkers Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Cancer Biomarkers Market Size

  • 6.1 Cancer Biomarkers Market Size, by Value
  • 6.2 Cancer Biomarkers Market Size, by Volume

7: Cancer Biomarkers Market, by Type

  • 7.1 Market Overview
  • 7.2 Genomic Biomarkers
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Proteomic Biomarkers
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Metabolomic Biomarkers
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Epigenetic Biomarkers
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Others
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region

8: Cancer Biomarkers Market, by Product

  • 8.1 Market Overview
  • 8.2 Assay Kits
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Reagents
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Instruments
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Software
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Cancer Biomarkers Market, by Services

  • 9.1 Market Overview
  • 9.2 Sample Preparation
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Biomarker Validation
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Biomarker Testing
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Data Analysis
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Cancer Biomarkers Market, by Technology

  • 10.1 Market Overview
  • 10.2 Next-Generation Sequencing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Polymerase Chain Reaction
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Immunoassays
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Mass Spectrometry
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Chromatography
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Cancer Biomarkers Market, by Application

  • 11.1 Market Overview
  • 11.2 Diagnostics
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Drug Discovery and Development
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Prognostics
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Risk Assessment
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Cancer Biomarkers Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Research Laboratories
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Pharmaceutical Companies
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Biotechnology Companies
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Academic Institutes
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Cancer Biomarkers Market, by Installation Type

  • 13.1 Market Overview
  • 13.2 On-Premise
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Cloud-Based
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Cancer Biomarkers Market, by Functionality

  • 14.1 Market Overview
  • 14.2 Detection
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Monitoring
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Profiling
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Cancer Biomarkers Market, by Stage

  • 15.1 Market Overview
  • 15.2 Early Detection
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Prognosis
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Therapeutic Response
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Recurrence
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Others
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region

16: Cancer Biomarkers Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Installation Type
    • 16.2.9 North America Market Size and Forecast, by Functionality
    • 16.2.10 North America Market Size and Forecast, by Stage
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Installation Type
      • 16.2.9.8 United States Market Size and Forecast, by Functionality
      • 16.2.9.9 United States Market Size and Forecast, by Stage
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Installation Type
      • 16.2.10.8 Canada Market Size and Forecast, by Functionality
      • 16.2.10.9 Canada Market Size and Forecast, by Stage
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Installation Type
    • 16.3.9 Europe Market Size and Forecast, by Functionality
    • 16.3.10 Europe Market Size and Forecast, by Stage
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Installation Type
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Functionality
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Installation Type
      • 16.3.10.8 Germany Market Size and Forecast, by Functionality
      • 16.3.10.9 Germany Market Size and Forecast, by Stage
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Installation Type
      • 16.3.11.8 France Market Size and Forecast, by Functionality
      • 16.3.11.9 France Market Size and Forecast, by Stage
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Installation Type
      • 16.3.12.8 Spain Market Size and Forecast, by Functionality
      • 16.3.12.9 Spain Market Size and Forecast, by Stage
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Installation Type
      • 16.3.13.8 Italy Market Size and Forecast, by Functionality
      • 16.3.13.9 Italy Market Size and Forecast, by Stage
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Installation Type
      • 16.3.14.8 Netherlands Market Size and Forecast, by Functionality
      • 16.3.14.9 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Installation Type
      • 16.3.15.8 Sweden Market Size and Forecast, by Functionality
      • 16.3.15.9 Sweden Market Size and Forecast, by Stage
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Installation Type
      • 16.3.16.8 Switzerland Market Size and Forecast, by Functionality
      • 16.3.16.9 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Installation Type
      • 16.3.17.8 Denmark Market Size and Forecast, by Functionality
      • 16.3.17.9 Denmark Market Size and Forecast, by Stage
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Installation Type
      • 16.3.18.8 Finland Market Size and Forecast, by Functionality
      • 16.3.18.9 Finland Market Size and Forecast, by Stage
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Installation Type
      • 16.3.19.8 Russia Market Size and Forecast, by Functionality
      • 16.3.19.9 Russia Market Size and Forecast, by Stage
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Installation Type
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Installation Type
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Functionality
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Installation Type
      • 16.4.9.8 China Market Size and Forecast, by Functionality
      • 16.4.9.9 China Market Size and Forecast, by Stage
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Installation Type
      • 16.4.10.8 India Market Size and Forecast, by Functionality
      • 16.4.10.9 India Market Size and Forecast, by Stage
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Installation Type
      • 16.4.11.8 Japan Market Size and Forecast, by Functionality
      • 16.4.11.9 Japan Market Size and Forecast, by Stage
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Installation Type
      • 16.4.12.8 South Korea Market Size and Forecast, by Functionality
      • 16.4.12.9 South Korea Market Size and Forecast, by Stage
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Installation Type
      • 16.4.13.8 Australia Market Size and Forecast, by Functionality
      • 16.4.13.9 Australia Market Size and Forecast, by Stage
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Installation Type
      • 16.4.14.8 Singapore Market Size and Forecast, by Functionality
      • 16.4.14.9 Singapore Market Size and Forecast, by Stage
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Installation Type
      • 16.4.15.8 Indonesia Market Size and Forecast, by Functionality
      • 16.4.15.9 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Installation Type
      • 16.4.16.8 Taiwan Market Size and Forecast, by Functionality
      • 16.4.16.9 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Installation Type
      • 16.4.17.8 Malaysia Market Size and Forecast, by Functionality
      • 16.4.17.9 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Installation Type
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Installation Type
    • 16.5.9 Latin America Market Size and Forecast, by Functionality
    • 16.5.10 Latin America Market Size and Forecast, by Stage
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Installation Type
      • 16.5.9.8 Brazil Market Size and Forecast, by Functionality
      • 16.5.9.9 Brazil Market Size and Forecast, by Stage
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Installation Type
      • 16.5.10.8 Mexico Market Size and Forecast, by Functionality
      • 16.5.10.9 Mexico Market Size and Forecast, by Stage
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Installation Type
      • 16.5.11.8 Argentina Market Size and Forecast, by Functionality
      • 16.5.11.9 Argentina Market Size and Forecast, by Stage
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Installation Type
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Installation Type
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Functionality
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Installation Type
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Installation Type
      • 16.6.10.8 UAE Market Size and Forecast, by Functionality
      • 16.6.10.9 UAE Market Size and Forecast, by Stage
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Installation Type
      • 16.6.11.8 South Africa Market Size and Forecast, by Functionality
      • 16.6.11.9 South Africa Market Size and Forecast, by Stage
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Installation Type
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Biocept
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Biodesix
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 NantHealth
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Exact Sciences
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Myriad Genetics
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Guardant Health
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 NeoGenomics Laboratories
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Caris Life Sciences
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Foundation Medicine
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Illumina
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Thermo Fisher Scientific
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 QIAGEN
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 PerkinElmer
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Roche Diagnostics
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Agilent Technologies
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
  • 18.16 Hologic
    • 18.16.1 Company Overview
    • 18.16.2 Company Snapshot
    • 18.16.3 Business Segments
    • 18.16.4 Business Performance
    • 18.16.5 Product Offerings
    • 18.16.6 Key Developmental Strategies
    • 18.16.7 SWOT Analysis
  • 18.17 Sysmex Corporation
    • 18.17.1 Company Overview
    • 18.17.2 Company Snapshot
    • 18.17.3 Business Segments
    • 18.17.4 Business Performance
    • 18.17.5 Product Offerings
    • 18.17.6 Key Developmental Strategies
    • 18.17.7 SWOT Analysis
  • 18.18 Bio-Rad Laboratories
    • 18.18.1 Company Overview
    • 18.18.2 Company Snapshot
    • 18.18.3 Business Segments
    • 18.18.4 Business Performance
    • 18.18.5 Product Offerings
    • 18.18.6 Key Developmental Strategies
    • 18.18.7 SWOT Analysis
  • 18.19 Quanterix
    • 18.19.1 Company Overview
    • 18.19.2 Company Snapshot
    • 18.19.3 Business Segments
    • 18.19.4 Business Performance
    • 18.19.5 Product Offerings
    • 18.19.6 Key Developmental Strategies
    • 18.19.7 SWOT Analysis
  • 18.20 Adaptive Biotechnologies
    • 18.20.1 Company Overview
    • 18.20.2 Company Snapshot
    • 18.20.3 Business Segments
    • 18.20.4 Business Performance
    • 18.20.5 Product Offerings
    • 18.20.6 Key Developmental Strategies
    • 18.20.7 SWOT Analysis